Results 261 to 270 of about 3,896,668 (306)
Some of the next articles are maybe not open access.

Influenza virus resistance to neuraminidase inhibitors

Drug Resistance Updates, 1998
The recent reports from Hong Kong of an avian influenza virus which caused the death of six people has served to remind us of the constant threat of pandemics posed by influenza. Recently, structure-based drug design has resulted in the discovery of a new class of antiviral agents which specifically target the influenza virus neuraminidase.
D B, Mendel, R W, Sidwell
openaire   +2 more sources

Virus Drug Resistance

1988
Drug resistance in viruses is generally considered to be an acquired heritable change which is characterised by relief from inhibition by a particular drug. This is always the result of one or more mutations in the virus genome, causing changes in targets for the drug or its metabolites which are reflected in a measurable difference in sensitivity ...
Hugh J. Field, Lindsey J. Owen
openaire   +1 more source

Resistance to Potato virus Y in Potato

2017
Growing potato cultivars resistant to Potato virus Y (PVY) offers the easiest and the most cost-effective solution to prevent the losses caused by PVY. Genes for resistance to PVY can be found in wild and cultivated potato species. Resistance genes functioning on the “gene-for-gene” basis are commonly used in breeding for resistance to PVY, because of ...
Jari P. T. Valkonen   +3 more
openaire   +1 more source

Influenza Virus Resistance to Antiviral Therapy

2013
Antiviral drugs for influenza therapy and prophylaxis are either of the adamantane or neuraminidase inhibitor (NAI) class. However, the NAIs are mainly prescribed nowadays, because of widespread adamantane resistance among influenza A viruses and ineffectiveness of adamantanes against influenza B.
Vries, Erhard   +4 more
openaire   +3 more sources

Virus-resistant plants

1991
About 10% of world crop production is lost annually because of plant diseases caused by bacteria, fungi and viruses (Fraser, 1985). Crop losses as a result of virus diseases can be especially serious in developing countries in tropical and subtropical regions.
openaire   +1 more source

Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward

Ca-A Cancer Journal for Clinicians, 2021
Amila K Nanayakkara, David E Greenberg
exaly  

Cervical cancer prevention and control in women living with human immunodeficiency virus

Ca-A Cancer Journal for Clinicians, 2021
Vikrant V Sahasrabuddhe   +2 more
exaly  

Virus Resistance

2009
Margaret G. Redinbaugh, Richard C. Pratt
openaire   +1 more source

Viruses and human cancer

Ca-A Cancer Journal for Clinicians, 1973
D W Allen, Philip Cole, David W Allen
exaly   +2 more sources

Home - About - Disclaimer - Privacy